Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q3SYG4 (
C18
)
23,707
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
C16H24O2
, Mr = 248.36, orthorhombic, P2(1)2(1)2(1), a = 9.0745 (9), b = 12.1499 (15), c = 12.8820 (10) A, V = 1420.3 (3) A3, Z = 4, Dx = 1.16 g cm-3, mu = 0.6946 cm-1, Mo K alpha, lambda = 0.7107 A, F(000) = 544, T = 298 K, R = 0.0624 for 1238 reflections where Fo greater than or equal to 4[sigma (Fo)]. The cyclooctane ring is in the usual boat-chair conformation. The bridgehead atom of the alkene group, C7, has one short [C7--C6 1.485 (6) A] and one long [C7--C11, 1.541 (6) A] Csp2--Csp3 bond. The alkene group is presumably distorted due to ring strain. The six C atoms comprising the group are non-planar [max. dev. 0.114 (7) A for C9]. The two nearly planar fragments (C6, C7, C8, C11 and C7, C8, C9,
C18
) are twisted by 8.9 (3) degrees.
...
PMID:The structure of (4R*,7R*)-4,10,11,11-tetramethyl-5- oxobicyclo[5.3.1]undec-1(10)-en-4-carbaldehyde. 208 21